Skip to main content

Currently Skimming:

7 Exploring Future Directions in the Treatment of Long COVID
Pages 87-92

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 87...
... There are multiple effects on the body such as nerve damage or organ damage, and multiple types of outcomes, including postural orthostatic tachycardia syndrome (POTS) , myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
From page 88...
... Deeks warned that excessive testing can be harmful, as it can lead "down various rabbit holes." Another issue with testing, he said, can be if a patient's subjective experience does not align with the objective findings. The goal of Long COVID treatment is to improve the patient's quality of life, and a holistic approach is helpful for meeting this aim, observed Deeks.
From page 89...
... Despite these challenges, targetable pathways have been identified and proof-of-concept studies are underway, which can help us understand the biology behind Long COVID as well as identify potential therapies. DISCUSSION Following Deeks' presentation, Andrea Lerner, physician and medical officer at the National Institute of Allergy and Infectious Diseases of the NIH, facilitated a panel discussion with Deeks, Frontera, and Nath, taking questions from the workshop participants.
From page 90...
... This was accomplished through massive investment from the federal government; this investment means that patients, regardless of financial means or insurance, can go to clinics and receive primary care, specialty care, social services, psychiatric care, and so on. Deeks said there is some discussion in California to fund this type of approach for Long COVID.
From page 91...
... The numbers of people who have been infected with Omicron is so massive, both in the United States and globally, that if the frequency of Long COVID is the same as with previous variants, "we are going to be in big trouble." There will be a massive wave of people with really serious issues, he said, that will overwhelm primary care physicians, primary care clinics, and Long COVID clinics. What are meaningful clinical trial outcomes for Long COVID therapeutics?
From page 92...
... Some conditions that are associated with Long COVID have been identified and have different mechanisms and therapies, for example, post-ICU syndrome and POTS. CLOSE OF WORKSHOP At the close of the workshop, Frontera thanked SSA for its support; thanked the speakers for sharing their knowledge, expertise, experience, and ideas; and thanked the workshop participants for their many thought-provoking comments and questions.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.